Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases

Autoimmunity Reviews

Volumn 11, Issue 4, 2012, Pages 276-280

  Anaya, Juan Manuel ^a   Kim Howard, Xana ^b   Prahalad, Sampath ^c   Cherñavsky, Alejandra ^d   Cañas, Carlos ^e   Rojas Villarraga, Adriana ^a   Bohnsack, John ^f   Jonsson, Roland ^g   Bolstad, Anne Isine ^g,h   Brun, Johan G ^g,h   Cobb, Beth ^b   Moser, Kathy L ^b   James, Judith A ^b,i   Harley, John B ^j   Nath, Swapan K ^b  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^e FUNDACIÓN VALLE DEL LILI   (Colombia)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF BERGEN   (Norway)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Autoimmune diseases; Genetic susceptibility; ITGAM

Indexed keywords

ALPHA INTEGRIN; ALPHA INTEGRIN M; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CELIAC DISEASE; ETHNICITY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; POWER ANALYSIS; REVIEW; RHEUMATOID ARTHRITIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIGENS, CD11B; AUTOIMMUNE DISEASES; DNA MUTATIONAL ANALYSIS; EUROPE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LATIN AMERICA; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84857037528     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.07.007     Document Type: Review

References (38)

1. Anaya J.M., Gomez L., Castiblanco J. Is there a common genetic basis for autoimmune diseases?. Clin Dev Immunol 2006, 13:185-195.
2. Nath S.K., Han S., Kim-Howard X., Kelly J.A., Viswanathan P., Gilkeson G.S., et al. A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus. Nat Genet 2008, 40:152-154.
3. Molineros J.E., Kim-Howard X., Deshmukh H., Jacob C.O., Harley J.B., Nath S.K. Admixture in Hispanic Americans: its impact on ITGAM association and implications for admixture mapping in SLE. Genes Immun. 2009 July, 10(5):539-545.
4. Han S., Kim-Howard X., Deshmukh H., Kamatani Y., Viswanathan P., Guthridge J.M., et al. Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE). Hum Mol Genet 2009, 18:1171-1180.
5. Fagerholm S.C., Varis M., Stefanidakis M., Hilden T.J., Gahmberg C.G. alpha-Chain phosphorylation of the human leukocyte CD11b/CD18 (Mac-1) integrin is pivotal for integrin activation to bind ICAMs and leukocyte extravasation. Blood 2006, 108:3379-3386.
6. Phipps-Green A.J., Topless R.K., Merriman M.E., Dalbeth N., Gow P.J., Harrison A.A., et al. No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population. Rheumatology (Oxford) 2009, 48:1614-1615.
7. Suarez-Gestal M., Calaza M., Dieguez-Gonzalez R., Perez-Pampin E., Pablos J.L., Navarro F., et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheum 2009, 60:2558-2564.
8. Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Rios-Fernandez R, et al. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis. Ann Rheum Dis, doi:10.1136/ard.2010.148874.
9. Coustet B., Agarwal S.K., Gourh P., Guedj M., Mayes M.D., Dieude P., et al. Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts. J Rheumatol 2011, 38:1033-1038.
10. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324.
11. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
12. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997, 20:1183-1197.
14. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001, 120:636-651.
15. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127.
16. Okuda D.T., Srinivasan R., Oksenberg J.R., Goodin D.S., Baranzini S.E., Beheshtian A., et al. Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain 2009, 132:250-259.
17. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
18. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575.
19. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213.
20. Nicodemus K.K. Catmap: case-control and TDT meta-analysis package. BMC Bioinformatics 2008, 9:130.
21. Anaya J.M., Delgado-Vega A.M., Castiblanco J. Genetic basis of Sjogren's syndrome. How strong is the evidence?. Clin Dev Immunol 2006, 13:209-222.
22. Anaya J.M. The autoimmune tautology. Arthritis Res Ther 2010, 12:147.
23. Castano-Rodriguez N., Diaz-Gallo L.M., Pineda-Tamayo R., Rojas-Villarraga A., Anaya J.M. Meta-analysis of HLA-DRB1 and HLA-DQB1 polymorphisms in Latin American patients with systemic lupus erythematosus. Autoimmun Rev 2008, 7:322-330.
24. Rojas-Villarraga A., Botello-Corzo D., Anaya J.M. HLA-Class II in Latin American patients with type 1 diabetes. Autoimmun Rev 2010, 9:666-673.
25. Buyon J.P., Shadick N., Berkman R., Hopkins P., Dalton J., Weissmann G., et al. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988, 46:141-149.
26. D'Agati V.D., Appel G.B., Estes D., Knowles D.M., Pirani C.L. Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 1986, 30:573-581.
27. Lhotta K., Neumayer H.P., Joannidis M., Geissler D., Konig P. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin Sci (Lond) 1991, 81:477-481.
28. Gustafsson R., Totterman T.H., Klareskog L., Hallgren R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990, 49:40-45.
29. Kourakata H., Takada T., Suzuki E., Enomoto K., Saito I., Taguchi Y., et al. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology 1999, 4:223-228.
30. McCormick L.L., Zhang Y., Tootell E., Gilliam A.C. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999, 163:5693-5699.
31. Zhang Y., McCormick L.L., Desai S.R., Wu C., Gilliam A.C. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002, 168:3088-3098.
32. Jarvinen T.M., Hellquist A., Koskenmies S., Einarsdottir E., Panelius J., Hasan T., et al. Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One 2010, 5:e14212.
33. Sanchez E., Nadig A., Richardson B.C., Freedman B.I., Kaufman K.M., Kelly J.A. et al. 2011, Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus, Ann Rheum Dis.
34. Kim-Howard X., Maiti A.K., Anaya J.M., Bruner G.R., Brown E., Merrill J.T., et al. ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry. Ann Rheum Dis 2010, 69:1329-1332.
35. Ehirchiou D., Xiong Y., Xu G., Chen W., Shi Y., Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med 2007, 204:1519-1524.
36. Tanasescu C., Balanescu E., Balanescu P., Olteanu R., Badea C., Grancea C., et al. IL-17 in cutaneous lupus erythematosus. Eur J Intern Med 2010, 21:202-207.
37. Kelley J.M., Edberg J.C., Kimberly R.P. Pathways: strategies for susceptibility genes in SLE. Autoimmun Rev 2010, 9:473-476.
38. Rojas-Villarraga A., Toro C.E., Espinosa G., Rodriguez-Velosa Y., Duarte-Rey C., Mantilla R.D., et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010, 9:229-232.